Investment Partners LTD. Purchases New Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Investment Partners LTD. acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the first quarter, according to its most recent filing with the SEC. The fund acquired 2,213 shares of the exchange traded fund’s stock, valued at approximately $210,000.

Several other institutional investors have also recently made changes to their positions in the stock. Avoro Capital Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $396,844,000. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of SPDR S&P Biotech ETF by 35.9% in the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,406,000 shares of the exchange traded fund’s stock worth $214,832,000 after buying an additional 635,000 shares in the last quarter. Employees Retirement System of Texas purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth $27,456,000. Blackstone Inc. boosted its stake in SPDR S&P Biotech ETF by 674.8% during the fourth quarter. Blackstone Inc. now owns 337,030 shares of the exchange traded fund’s stock valued at $30,093,000 after buying an additional 293,530 shares during the period. Finally, MBB Public Markets I LLC grew its position in SPDR S&P Biotech ETF by 67.0% during the third quarter. MBB Public Markets I LLC now owns 514,411 shares of the exchange traded fund’s stock worth $37,562,000 after buying an additional 206,337 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI traded down $0.51 on Friday, hitting $92.35. The company’s stock had a trading volume of 2,059,376 shares, compared to its average volume of 10,679,209. The company has a market capitalization of $7.04 billion, a PE ratio of 11.47 and a beta of 1.11. The company has a 50-day simple moving average of $89.75 and a 200 day simple moving average of $90.63. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.